Every increment in corporate competitiveness begins with the judgment and steering of decision‑makers. Choices at every stage—target and technology‑route selection, product ideation and clinical advancement, BD deals, market access, capital allocation, and AI empowerment—shape the destiny of a company and subtly influence the R&D landscape and competitive dynamics of the entire therapeutic area. Whether the industry is experiencing rapid growth or fierce cutthroat competition, the quality of decision‑making is the watershed that determines how high a company can rise.

The China Healthcare Decision‑Makers Conference (CHDC) is positioned as a platform for intellectual exchange and industrial collaboration among healthcare decision‑makers. The summit covers a wide array of specific decision‑making scenarios across the full value chain of biopharma and the entire life cycle of innovative drugs, bringing together senior executives from leading pharmaceutical companies, frontline clinical PIs, regulatory review experts, and partners from top investment institutions. Through high‑quality conference content, it helps industry decision‑makers clarify their directions, thereby enhancing decision quality and driving both business success and the high‑quality development of the pharmaceutical industry.

We firmly believe that at the 2026 China Healthcare Decision‑Makers Conference, you will not only take away actionable decision‑making frameworks and methodologies, but also discover partners that align with your company’s business needs—ultimately turning the exchanges you have at the event into a real starting point for business advancement. We look forward to meeting you again in Beijing.

• Conference Highlights

1. Focused Scenarios, Battle‑Ready Content
   Covering the key decision‑making scenarios of pharmaceutical companies, the conference features in‑depth discussions on common challenges in strategic decisions, product ideation, clinical development, going global, and internationalisation, helping participants find a judgment framework suitable for their own business development.

2. Building Consensus, Driving Success
   By bringing together decision‑makers from government, industry, academia, research, and clinical practice, the event breaks down cognitive silos across policy‑making, strategic choices, R&D practices, and industrial implementation. It enables attendees to move beyond a single perspective, calibrate their own decisions within a more complete industrial coordinate system, and ultimately support business success.

3. Linking Resources, Fostering Collaboration
   The conference gathers leading domestic and international pharma companies, innovative biotechs, and industrial capital for face‑to‑face dialogue, creating a genuine arena for cross‑border exchanges and resource matching. CHDC is not merely an exchange of views—it is the starting point for overseas partners and China’s innovation community to build trust, discover opportunities, and initiate collaborations.